Adial Pharmaceuticals Inc (ADIL)
1.70
-0.09
(-5.03%)
USD |
NASDAQ |
May 03, 15:12
Adial Pharmaceuticals Free Cash Flow (Quarterly): -1.223M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.223M |
| September 30, 2023 | -1.391M |
| June 30, 2023 | -1.894M |
| March 31, 2023 | -2.299M |
| December 31, 2022 | -1.751M |
| September 30, 2022 | -3.404M |
| June 30, 2022 | -3.534M |
| March 31, 2022 | -2.497M |
| December 31, 2021 | -2.373M |
| September 30, 2021 | -3.530M |
| June 30, 2021 | -3.237M |
| March 31, 2021 | -2.874M |
| December 31, 2020 | -2.614M |
| September 30, 2020 | -2.208M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.9852M |
| March 31, 2020 | -1.825M |
| December 31, 2019 | -1.753M |
| September 30, 2019 | -1.724M |
| June 30, 2019 | -1.140M |
| March 31, 2019 | -1.721M |
| December 31, 2018 | -1.104M |
| September 30, 2018 | -0.9913M |
| June 30, 2018 | -0.1889M |
| March 31, 2018 | -0.2143M |
| December 31, 2017 | -0.1221M |
| September 30, 2017 | -0.1368M |
| June 30, 2017 | -0.1506M |
| March 31, 2017 | -0.0854M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.534M
Minimum
Jun 2022
-0.9852M
Maximum
Jun 2020
-2.224M
Average
-2.208M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| BioVie Inc | -5.910M |
| BioSig Technologies Inc | -2.946M |
| Precision BioSciences Inc | -8.418M |
| Humacyte Inc | -19.20M |
| Monogram Orthopaedics Inc | -3.136M |